Dynavax Technologies Corporation
DVAX
$10.40
$0.100.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.89% | 35.77% | 39.09% | 27.32% | 24.36% |
| Total Other Revenue | -1.03% | 8.83% | -78.29% | -82.14% | -5.30% |
| Total Revenue | 29.33% | 34.21% | 29.56% | 15.99% | 22.48% |
| Cost of Revenue | 13.47% | 36.76% | 42.67% | 0.29% | -42.70% |
| Gross Profit | 33.34% | 31.96% | 20.99% | 25.80% | 71.77% |
| SG&A Expenses | 21.31% | 22.99% | -0.04% | 13.25% | 12.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.67% | 27.66% | 15.08% | 7.79% | 7.67% |
| Operating Income | 124.98% | -10.50% | 108.83% | 101.13% | 624.29% |
| Income Before Tax | 42.33% | -751.31% | 665.96% | 40.10% | 254.31% |
| Income Tax Expenses | -29.12% | 36.02% | -25.48% | 1,612.93% | 353.61% |
| Earnings from Continuing Operations | 64.42% | -1,001.93% | 3,119.18% | 23.10% | 231.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.42% | -1,001.93% | 3,119.18% | 23.10% | 231.86% |
| EBIT | 124.98% | -10.50% | 108.83% | 101.13% | 624.29% |
| EBITDA | 109.62% | -10.87% | 132.65% | 86.48% | 2,836.54% |
| EPS Basic | 80.34% | -1,048.66% | 3,141.18% | 21.12% | 225.84% |
| Normalized Basic EPS | 56.04% | -43.12% | 677.08% | 48.35% | 249.02% |
| EPS Diluted | 75.85% | -1,000.00% | 43,400.00% | 20.81% | 207.12% |
| Normalized Diluted EPS | 58.87% | -43.12% | 563.83% | 50.09% | 248.55% |
| Average Basic Shares Outstanding | -8.86% | -4.09% | -1.10% | 1.66% | 1.78% |
| Average Diluted Shares Outstanding | -10.43% | -4.09% | 14.81% | 0.40% | 1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |